Clinical trial
Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel
NCT05163730 is registered in ClinicalTrials.gov with Abbott Rapid Diagnostics Jena GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel
- Lead sponsor
- Abbott Rapid Diagnostics Jena GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2021
- Completion date
- February 11, 2022
- Enrollment
- 2,472 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, influenza a, influenza type b